Published in J Natl Cancer Inst on August 01, 1982
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol (2010) 12.64
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ (1988) 9.71
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Breast screening: time for a rethink? BMJ (1989) 5.52
Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ (1995) 4.83
How valid are mammography self-reports? Am J Public Health (1990) 3.86
Physicians' recommendations for mammography: do tailored messages make a difference? Am J Public Health (1994) 3.54
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys. Am J Public Health (1994) 3.33
Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status. J Clin Oncol (2015) 3.19
Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women. Am J Public Health (2003) 3.07
Late-stage diagnosis of breast cancer in women of lower socioeconomic status: public health implications. Am J Public Health (1989) 2.93
Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res (2005) 2.81
Response by women aged 65-79 to invitation for screening for breast cancer by mammography: a pilot study. BMJ (1990) 2.51
Evaluation of diagnostic procedures. BMJ (2002) 2.43
Possible net harms of breast cancer screening: updated modelling of Forrest report. BMJ (2011) 2.22
Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology (2012) 2.14
The debate over mass mammography in Britain. The case against. BMJ (1988) 2.06
Quality of life following a false positive mammogram. Br J Cancer (1990) 1.98
A study guided by the Health Belief Model of the predictors of breast cancer screening of women ages 40 and older. Public Health Rep (1991) 1.97
The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer (1989) 1.94
The Edinburgh randomised trial of screening for breast cancer: description of method. Br J Cancer (1984) 1.93
Psychiatric morbidity after screening for breast cancer. J Epidemiol Community Health (1986) 1.84
Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health (2001) 1.83
Breast screening, prognostic factors and survival--results from the Swedish two county study. Br J Cancer (1991) 1.80
Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol (2009) 1.76
Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ (2001) 1.74
Breast cancer size and stage in Hispanic American women, by birthplace: 1992-1995. Am J Public Health (2001) 1.72
Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer (1984) 1.71
Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits. CMAJ (1996) 1.69
The acceptance and completion of mammography by older black women. Am J Public Health (1989) 1.68
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer (1994) 1.65
Adherence of low-income women to cancer screening recommendations. J Gen Intern Med (2002) 1.63
Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features. Ann Surg (1988) 1.55
Mammography screening: how important is cost as a barrier to use? Am J Public Health (1994) 1.54
The Canadian National Breast Screening Study: opportunity for a rethink. CMAJ (1992) 1.45
Observer variability in reporting of breast lesions. J Clin Pathol (1985) 1.43
Why isn't every woman over 40 in a breast cancer detection program? West J Med (1988) 1.39
Histopathology of benign non-palpable breast lesions identified by mammography. J Clin Pathol (1988) 1.39
The first national public breast cancer screening program in Saudi Arabia. Ann Saudi Med (2010) 1.39
Outcomes of multimodality breast screening for women at increased risk of familial breast cancer. World J Surg (2010) 1.38
Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer. Ann Surg (1992) 1.34
Evaluating women's attitudes and perceptions in developing mammography promotion messages. Public Health Rep (1990) 1.31
Breast self-examination for the early detection of breast cancer: a USSR/WHO controlled trial in Leningrad. Bull World Health Organ (1987) 1.29
Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited. Am J Public Health (1992) 1.26
Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut (1990) 1.24
The debate over mass mammography in Britain. The case for. BMJ (1988) 1.16
Demands on surgical inpatient services after mass mammographic screening. Br Med J (Clin Res Ed) (1986) 1.15
Screening for prostate cancer. West J Med (1995) 1.12
Which prescriptive screening programmes are worth while? J Epidemiol Community Health (1984) 1.12
Breast cancer detection: radiologists' performance using mammography with and without automated whole-breast ultrasound. Eur Radiol (2010) 1.12
Role of mammography in diagnosis of breast cancer in an inner-city hospital. J Natl Med Assoc (2000) 1.10
Do vouchers improve breast cancer screening rates? Results from a randomized trial. Health Serv Res (1998) 1.10
Breast and cervical cancer screening among low-income women: impact of a simple centralized HMO intervention. J Natl Med Assoc (1996) 1.04
Application of magnetic resonance imaging to early detection of breast cancer. Breast Cancer Res (2001) 1.04
Effect on breast cancer screening response in The Netherlands of inviting women for an additional scientific investigation. J Epidemiol Community Health (1994) 1.03
Breast cancer risk and participation in mammographic screening. Am J Public Health (1989) 1.03
A simulation model of the natural history of human breast cancer. Br J Cancer (1985) 1.02
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res Treat (2011) 1.00
Prognosis in women with interval breast cancer: population based observational cohort study. BMJ (2012) 1.00
A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol (2000) 0.99
Mammography and screening for breast cancer. Br Med J (Clin Res Ed) (1986) 0.99
A centralised cytology screening programme for cervical cancer in Florence. J Epidemiol Community Health (1990) 0.98
Redesigning primary care processes to improve the offering of mammography. The use of clinic protocols by nonphysicians. J Gen Intern Med (1997) 0.97
The predictive value of positive test results in screening for breast cancer by mammography in the Nijmegen programme. Br J Cancer (1987) 0.97
How effective is screening for breast cancer? BMJ (2000) 0.96
Screening for breast cancer: current attitudes and practice. Can Fam Physician (1989) 0.96
Factors associated with non-participation of women in a breast cancer screening programme in a town in northern Italy. J Epidemiol Community Health (1991) 0.94
Evaluation of breast self-examination teaching materials in a primary care setting. J R Coll Gen Pract (1985) 0.93
Evaluation of a proposed breast cancer screening regimen. BMJ (1988) 0.93
Tumour size predicts long-term survival among women with lymph node-positive breast cancer. Curr Oncol (2012) 0.93
Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer (2004) 0.93
A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Community Health (1992) 0.92
Differences in the timeliness of diagnosis, breast and cervical cancer, San Francisco 1974-85. Am J Public Health (1989) 0.92
A two-step intervention of increase mammography among women aged 65 and older. Am J Public Health (1997) 0.92
Use of risk factors to allocate schedules for breast cancer screening. J Epidemiol Community Health (1988) 0.92
The costs and effects of cervical and breast cancer screening in a public hospital emergency room. The Cancer Control Center of Harlem. Am J Public Health (1997) 0.91
Screening mammography. West J Med (1988) 0.91
Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study. Br J Cancer (1993) 0.91
Breast cancer knowledge, beliefs, and screening behaviors among low-income, elderly black women. J Natl Med Assoc (2003) 0.90
A pilot study of eye movement during mammography interpretation: eyetracker results and workstation design implications. J Digit Imaging (1997) 0.89
Health insurance and mammography: would a Medicare buy-in take us to universal screening? Health Serv Res (2002) 0.89
Breast cancer screening: its impact on clinical medicine. Br J Cancer (1990) 0.89
Breast cancer risk for women with a false positive screening test. Br J Cancer (1988) 0.88
Randomisation by cluster and the problem of social class bias. J Epidemiol Community Health (1989) 0.88
Were our estimates of overdiagnosis with mammography screening in the United States "based on faulty science"? Oncologist (2014) 0.87
Concordance of population-based estimates of mammography screening. Prev Med (2007) 0.87
Practice of breast self examination: disease extent at diagnosis and patterns of surgical care. A report from an Italian study. GIVIO (Interdisciplinary Group for Cancer Care Evaluation). J Epidemiol Community Health (1991) 0.86
Influence of additional breast ultrasound on cancer detection in a cohort study for quality assurance in breast diagnosis--analysis of 102,577 diagnostic procedures. Eur Radiol (2009) 0.86
Treatment of screen detected ductal carcinoma in situ: a silver lining within a grey cloud? Br J Cancer (1990) 0.86
The patient's appraisal of the cosmetic result of segmental mastectomy in benign and malignant breast disease. Ann Surg (1988) 0.85
Is needle-directed breast biopsy overused? West J Med (1994) 0.85
Person-years of life lost due to cancer in the United States, 1970 and 1984. Am J Public Health (1989) 0.85
Controversy over mammography screening. BMJ (1988) 0.84
Cancer control planning and establishment of priorities for intervention by a state health department. Public Health Rep (1995) 0.84
Will screening for breast cancer reduce mortality? Evidence from the first year of screening in Avon. Ann R Coll Surg Engl (1993) 0.83
Breast-cancer screening. Can Fam Physician (1987) 0.83
Leading the way in breast cancer screening and prevention. J Gen Intern Med (2004) 0.82
Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA (2001) 11.31
Evidence on screening for breast cancer from a randomized trial. Cancer (1977) 7.91
Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst (1993) 6.02
Periodic breast cancer screening in reducing mortality from breast cancer. JAMA (1971) 5.91
A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst (1995) 4.29
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet (1996) 4.21
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA (1993) 3.71
The reluctant participant in a breast cancer screening program. Public Health Rep (1968) 3.60
Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry (1984) 3.55
A comparison of the requirements for primary care physicians in HMOs with projections made by the GMENAC. N Engl J Med (1986) 3.54
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet (1997) 3.40
Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol (1986) 3.34
Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33
Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18
Oral-contraceptive use in relation to myocardial infarction. Lancet (1979) 3.04
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96
Comprehensive drug surveillance. JAMA (1970) 2.92
Mammography and clinical examination in mass screening for cancer of the breast. Cancer (1967) 2.80
Functional recovery and medical costs of trauma: an analysis by type and severity of injury. J Trauma (1988) 2.74
Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65
The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med (1985) 2.64
Induction of an active transport system for glucose 6-phosphate in Escherichia coli. Arch Biochem Biophys (1966) 2.53
Mental health and social characteristics of the homeless: a survey of mission users. Am J Public Health (1986) 2.50
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
A case-control study of baldness in relation to myocardial infarction in men. JAMA (1993) 2.49
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. Am J Public Health (1972) 2.35
Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol (1991) 2.35
Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30
Current practice of artificial insemination by donor in the United States. N Engl J Med (1979) 2.24
Medical economics survey-methods study: cost-effectiveness of alternative survey strategies. Med Care (1978) 2.22
Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol (2003) 2.17
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
The search for risk factors in breast cancer. Am J Public Health Nations Health (1968) 2.16
The economic impact of traumatic injuries. One-year treatment-related expenditures. JAMA (1988) 2.15
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13
The Abbreviated Injury Scale and Injury Severity Score. Levels of inter- and intrarater reliability. Med Care (1985) 2.11
Methyl-coenzyme M, an intermediate in methanogenic dissimilation of C1 compounds by Methanosarcina barkeri. J Bacteriol (1980) 2.11
Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh (1975) 2.10
Prepregnant weight in relation to risk of neural tube defects. JAMA (1996) 2.02
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
New techniques in mass screening for breast cancer. Cancer (1971) 2.01
Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA (1966) 2.00
Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med (1981) 1.96
Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med (1990) 1.95
Reproductive factors and risk of myocardial infarction. Am J Epidemiol (1992) 1.94
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Multivitamin supplementation and risk of birth defects. Am J Epidemiol (1999) 1.91
Noncontraceptive estrogens and myocardial infarction in young women. JAMA (1980) 1.88
Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr (1985) 1.87
End result measurements of quality of medical care. Milbank Mem Fund Q (1967) 1.87
Relevance of correlates of infant deaths for significant morbidity at 1 year of age. Am J Obstet Gynecol (1980) 1.85
Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health Nations Health (1968) 1.85
Vasectomy and the risk of prostate cancer. Am J Epidemiol (1990) 1.84
Like mother, like child: intergenerational patterns of age at first birth and associations with childhood and adolescent characteristics and adult outcomes in the second generation. Dev Psychol (1998) 1.81
Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. Arch Gen Psychiatry (1987) 1.81
Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med (1983) 1.80
Patterns of medical use by the indigent aged under two systems of medical care. Am J Public Health Nations Health (1967) 1.80
Ventricular premature beats and mortality after myocardial infarction. N Engl J Med (1977) 1.79
Calcium channel blockers and the risk of cancer. JAMA (1998) 1.78
Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol (1989) 1.76
Stature and the risk of myocardial infarction in women. Am J Epidemiol (1990) 1.73
The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol (1999) 1.73
Validation of an in vitro biofilm model of supragingival plaque. J Dent Res (2001) 1.73
Endogenous hormones and breast cancer: a prospective cohort study. Breast Cancer Res Treat (1991) 1.68
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (1999) 1.67
"Low yield" cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med (1989) 1.66
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
Value of mammography in reduction of mortality from breast cancer in mass screening. Am J Roentgenol Radium Ther Nucl Med (1973) 1.65
Breast cancer and oral contraceptive use. Am J Epidemiol (1984) 1.64
Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA (1981) 1.64
Fatal drug reactions among medical inpatients. JAMA (1971) 1.64
Relation of cigarette smoking to myocardial infarction in young women. N Engl J Med (1978) 1.62
Clinical outcomes resulting from telemedicine interventions: a systematic review. BMC Med Inform Decis Mak (2001) 1.62
Lead time gained by diagnostic screening for breast cancer. J Natl Cancer Inst (1968) 1.61
Comparisons of poverty and nonpoverty groups on dental status, needs, and practices. J Public Health Dent (1975) 1.61
Adequacies and inadequacies of breast examinations by physicians. Cancer (1969) 1.60
Designing a community study of moderately to severely disabled older women: the Women's Health and Aging Study. Ann Epidemiol (1999) 1.59